ArticleJournal of clinical medicine2025

Post-Marketing Safety of Spinal Muscular Atrophy Therapies: Analysis of Spontaneous Adverse Drug Reactions from EudraVigilance.

Andrej Belančić et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.